Page last updated: 2024-10-24

cetylpyridinium and Glial Cell Tumors

cetylpyridinium has been researched along with Glial Cell Tumors in 1 studies

Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.

Research Excerpts

ExcerptRelevanceReference
"Cetylpyridinium chloride has been administered in humans as a safe drug-disinfectant for several decades, and we report here that under in vitro conditions, cetylpyridinium chloride kills glioblastoma cells in a dose dependent manner at a higher efficacy compared to current standard of care drug, temozolomide."1.56Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer. ( Allen, SA; Angelastro, JM; Cortopassi, GA; Datta, S; Sandoval, J; Sears, T; Tomilov, A; Woolard, K, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Allen, SA1
Datta, S1
Sandoval, J1
Tomilov, A1
Sears, T1
Woolard, K1
Angelastro, JM1
Cortopassi, GA1

Other Studies

1 other study available for cetylpyridinium and Glial Cell Tumors

ArticleYear
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer.
    Mitochondrion, 2020, Volume: 50

    Topics: Adenylate Kinase; Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Cell Line; Cell Surv

2020